|Articles|April 1, 2004

Volume 0

Colace/Peri-Colace

Purdue Pharmaceutical Products' (Stamford, Conn) Colace/Peri-Colace laxatives are used to treat constipation. Colace's active ingredient is docusate sodium. Docusate sodium allows water and fats to get into the stool and helps to soften fecal material. Colace is available in capsules, syrup, liquid 1% solution, and glycerin suppositories. Peri-Colace's active ingredients are docusate sodium and standardized senna concentrate. These ingredients help relieve occasional constipation. Peri-Colace is available in tablets. For more information: www.peri-colace.com

Articles in this issue

over 22 years ago

Article

RxPRODUCT NEWS PROFILE: Caduet

over 22 years ago

Article

COMPOUNDING HOTLINE

over 22 years ago

Article

Case Studies

over 22 years ago

Article

Buddies Are Good for the Heart

over 22 years ago

Article

Low-Fat Diet Shows Promise for Prostate Cancer

over 22 years ago

Article

Rage Is Connected to Stroke Risk

over 22 years ago

Article

InnoLet

over 22 years ago

Article

TampAlerT

over 22 years ago

Article

Low Testosterone Is Linked with Alzheimer's Disease

over 22 years ago

Article

Wound Care in an Aging Population: Special Considerations

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Colace/Peri-Colace

Articles in this issue

Related Content

The Work Between the Goals

The Fit Trap: Is Residency Selection Becoming a Popularity Contest?

A Practical Guide to Peer Review in Pharmacy Practice

Point of Pure Return: Denileukin Diftitox-cxdl for Cutaneous T-Cell Lymphoma

Navigating Menopause: Holistic Symptom Management and HRT Counseling in Pharmacy Practice

Latest CME

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

NEIAP Conference 2026

PBMI 2026

Lymphoma Day of Education 2026

Infectious Disease Day of Education 2026

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Biomarker Testing in Practice: Navigating Modalities and Multidisciplinary Decision-Making

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

New Drug Approvals for 2025 (Pharmacy Technician Credit)

Advancing HER2-Driven Cancer Care, Biomarker Testing, and Pharmacist Innovation

Navigating Outpatient Bispecific Antibody Administration in Lymphoma: Practical Solutions for Community Oncology Practices

Infectious Disease Day of Education 2026

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

The Pharmacist's Role in Palliative and End of Life Symptom Management

The Educated Pharmacist - Weighing In: Translating Evidence to Practice — A Multidisciplinary Analysis of Obesity Pharmacotherapy Implementation and Team-Based Care

NEIAP 2026 Annual Forum

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

New Oncology Therapy Approvals for 2025 (Pharmacist Credit)

Lymphoma Day of Education 2026

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Targeting the Complement Cascade: Evolving Strategies in the Management of Complement-Mediated Kidney Diseases

New Oncology Therapy Approvals for 2025 (Pharmacy Technician Credit)

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

Payment for Pharmacist Services: 2025 Update

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Care in Polycythemia Vera and Essential Thrombocythemia: Emerging Evidence, Evolving Strategies, and the Pharmacist’s Role

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Advancing the Management of Hidradenitis Suppurativa: Emerging Therapies and Managed Care Strategies Across Patient Populations

Improving Outcomes in Fibrosing Interstitial Lung Diseases: Exploring Novel Mechanisms of Action and New Indications to Inform Clinical and Managed Care Decision-Making

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer